Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States.

Saved in:
Bibliographic Details
Title: Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States.
Authors: Castillo JJ; Dana-Farber Cancer Institute Boston Massachusetts USA., Kingsley EC; Comprehensive CancerCenters of Nevada Las Vegas Nevada USA., Narang M; US Oncology Research Maryland Hematology Oncology Columbia Maryland USA., Yimer HA; Texas Oncology US Oncology Research Tyler Texas USA., Dasanu CA; Lucy Curci Cancer Center Eisenhower Health Rancho Mirage California USA., Melear JM; US Oncology Research Texas Oncology, Austin Midtown Austin Texas USA., Coleman M; Clinical Research Alliance Weill Cornell Medicine New York New York USA., Farber CM; Atlantic Hematology Oncology Morristown Medical Center Morristown New Jersey USA., Shulman J; Icahn School of Medicine at Mount Sinai New York New York USA., Mantovani EH; BeiGene (Beijing) Co. Ltd. Beijing China and BeiGene Inc San Mateo California USA., Zhang X; BeiGene (Beijing) Co. Ltd. Beijing China and BeiGene Inc San Mateo California USA., Cohen A; BeiGene (Beijing) Co. Ltd. Beijing China and BeiGene Inc San Mateo California USA., Huang J; BeiGene (Beijing) Co. Ltd. Beijing China and BeiGene Inc San Mateo California USA.
Source: EJHaem [EJHaem] 2023 Jan 11; Vol. 4 (1), pp. 301-304. Date of Electronic Publication: 2023 Jan 11 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2688-6146
DOI:10.1002/jha2.619